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This paper supports the thesis that significant improvement of PET output response to clinical questions can be
achieved by innovation in radionuclide production. Moreover, that development can be performed with the resources
available at a clinical centre. Carbon-10 production parameters studies are used as example. A technical methodology
for measurement of excitation function of nuclear reactions yielding short-lived radionuclides, performed to measure
cross section values of the 10B(p,n)10C reaction in a PET-devoted cyclotron, is presented.
r 2006 Elsevier Ltd. All rights reserved.1. Introduction
Positron emission tomography (PET) is a quantitative
functional imaging technique with numerous applica-
tions in both clinical practice and research. The high
sensitivity derived from the use of radioisotopic meth-
ods, together with the availability of positron-emitting
isotopes of the most prevailing atoms in the organic
molecules, confers to PET a unique role within the non-
invasive molecular imaging techniques for studies in
man (Jones, 1996).
A PET study can be, synthetically, divided into a set of
sequential tasks: production of the positron-emitting
nuclides, radiosynthesis and labelling, radiation emission
and detection, image processing and analysis. Although
all steps are important for the quality and relevance of the
final result, a concentration of methodological innovationee front matter r 2006 Elsevier Ltd. All rights reserv
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ing author. Fax: +351239813395.
ess: falves@estescoimbra.pt (F. Alves).and development in the post-acquisition and image
quantification processes has been observed in the past
few years. This trend cannot be detached from the
availability of established radiotracers for quantification
of several clinically important processes (e.g., fluor-18-
labelled fluorodeoxyglucose for the oxidative metabolism
and oxygen-15-labelled water for regional cerebral blood
flow), decisive for the success of PET and the widespread
proliferation of small dedicated clinical centres. This
scenario contributes to generalise the idea that there is not
much more to be developed in the basic areas (radio-
nuclide production and radiochemistry), deemed as
needing ‘‘large resources’’.
We hereby make an effort to invert this trend,
showing that methodological and technical innovation
involving research in radionuclide production can lead
to the improvement of PET output response to clinical
questions. Moreover, this development can be per-
formed within a clinically oriented PET centre with a
low/medium energy cyclotron.ed.
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of nuclear reactions
Radionuclide production in a cyclotron is based upon
target material nuclide transmutation. The leading
physical process, a nuclear reaction induced by cyclo-
tron beam irradiation, can be quantified by its excitation
function, which plots the reaction cross section (measure
of the physical probability of occurrence) as function of
the incoming beam energy.
Unknown excitation functions are usually determined
within the clinically oriented cyclotron centre by an
experimental method commonly called ‘‘stacked foil’’
(Qaim, 1982). This traditional protocol consists of a
single irradiation of a stack of foils, followed by
sequential measurement of the activity induced in each
foil. It is assumed that the decay rate of the nuclear
reaction product is small when compared with the time
required to sequentially measure the activity in the foils
ensuring adequate counting statistics. Therefore, the
decay constant is a limiting factor for the number of foils
that can be measured, bearing in mind that the
possibility of simultaneously measuring each foil in a
different detector is not cost-effective.3. Proposed methodology for measurement of excitation
functions of nuclear reactions yielding short-lived
radionuclides
In order to measure excitation functions of nuclear
reactions yielding short-lived products, an alternative
methodology is proposed. Instead of a single irradiation,
the proposed method uses several irradiations of stacks
where only one of the foils is under study. Each
irradiation is followed by activity measurement. The
remaining foils in the stacks, of calibrated thickness and
adequate composition, determine the effective energy of
the beam in the foil under study. The proper use of this
methodology implies that all cyclotron parameters
remain constant during irradiations and in-between
different irradiations. However, in the common cyclo-
tron operating protocols, obtaining a determined value
for the beam current is an interactive process between
operator settings and ion beam response. Such a process
is hardly compatible with the proposed method, forcing
a reprogramming of the cyclotron beam production
sequence. The main beam switch will operate the RF
system, instead of the ion source. The ion source
parameters are set and stabilized before the irradiation
protocol, not requiring further adjustment by the
cyclotron operator. This way, the source will be
producing, at constant rate, ions that, when the RF is
switched on, are just accelerated, resulting in a constant
current beam. Practical application of the proposed
methodology, including the cyclotron-modified proto-col, leads to results with precision comparable to the one
achieved with the conventional ‘‘stacked-foil’’ method.4. Cyclotron production of positron emitters for medical
use: physical/chemical constrains
The excitation functions of the different nuclear
reactions that can produce a certain nuclide, in the
experimental conditions (i.e., available projectiles and
respective energy), determine the hierarchy of these
reactions in terms of production efficiency. However, the
process of establishing a production protocol for a
certain radioisotope is not restricted to the choice of the
nuclear reaction that leads to the largest production
yield of that isotope. It also requires further evaluation
of the candidate reactions, bearing in mind the physical/
chemical characteristics, commercial availability and
price of the target material, and the viability, yield and
timing of the extraction/separation process of the
nuclide under production. Moreover, the relation
between a given projectile-target pair and a certain
nuclear reaction is not necessarily univocal, even for a
certain beam energy value. Thus, other competing
nuclear reactions, leading to impurities in the final
product, have often to be taken into account. Even-
tually, the impossibility of keeping low levels of
impurities may preclude the use of the production
protocol based in a certain nuclear reaction. When these
impurities are not radioisotopes of the intended nuclide,
they can be separated, referring to the physical/chemical
characterization of the target. If they correspond to
radioisotopes of the intended nuclide, a compromise, in
terms of maximising production and minimising impu-
rities, can be achieved using an appropriate projectile
energy range in the target. This optimisation process
implies the knowledge of the beam energy degradation
in the target material, reflecting the correspondent
stopping power. The stopping power of most elements
for the light projectiles typically accelerated in cyclo-
trons, in a large range of beam energy values, is readily
available from literature (Williamson et al., 1966) and/or
can easily be calculated within acceptable error tolerance
from algorithms based on Bethe’s theoretical expression
(Bethe, 1930).5. A clinical question answered by a new positron emitter,
carbon-10 (10C)
A continuous tracer administration method (Jones et
al., 1976), based on Kety’s single compartment model
(Kety, 1951), has been used since the 1980s for mapping
regional cerebral blood flow (rCBF) using PET (Frack-
owiak et al., 1980). Using oxygen-15 (as tracer in H2
15O,
C15O2 or C
15O), this steady-state imaging methodology
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Fig. 1. On-line [10C]CO2 from cyclotron-produced
10C.
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blood flow to amount of tracer ratio, due to the
relatively slow decay rate of the positron emitter
(l ¼ 0:34min1) (Huang et al., 1979).
Neon-19 (Ne19, l ¼ 2:4min1) would overcome this
effect (Kearfott et al., 1983), but has low blood
solubility.
Nowadays, the method of choice for rCBF mapping
with PET is a variation of the steady-state methodology,
based on a H2
15O bolus injection (Huang et al., 1982),
imposing anyway a typical interval of 10min between
repeated studies.
In this context, facing a clinical question demanding
activation studies with time intervals down to 2min
between changes in stimuli, the established methodology
is unable to provide an answer.
A qualified reply to the clinical question can be
achieved by the introduction of 10C-labelled carbon
dioxide ([10C]CO2) as a new tracer for mapping regional
cerebral blood flow with PET (Jensen et al., 1998;
Nickles et al., 1998). 10C decay rate (l ¼ 2:2min1), fast
when compared to its transport kinetics, and CO2 good
solubility in blood and tissue, allows steady-state flow
imaging using single-frame static data acquisitions
during continuous tracer administration, with negligible
intrinsic methodological limitations (Jensen et al., 1999).6. Cyclotron production of 10C
The potential for widespread use of this tracer
depends on the possibilities of 10C production in PET
dedicated cyclotrons. It should also be taken in mind
that the viability of continuous steady-state administra-
tion of [10C]CO2 imposes that longer-lived radionuclide
impurities do not build up during production and
depends on a reliable on-line chemistry system.
The most plausible choice for 10C production is the
10B(p,n)10C reaction. Since monoisotopic 10B is unavail-
able, the simultaneous production of 11C is unavoidable
through the 11B(p,n)11C.
The previously unknown excitation function for the
reaction 10B(p,n)10C was experimentally determined
(Alves et al., 2000) using the proposed methodology
for measurement in the situation of nuclear reactions
yielding short-lived products. The results obtained were
used, together with data for the 11B(p,n)11C reaction,
available from the literature (Firouzbakht et al., 1998) to
optimise production parameters, namely proton beam
energy and target thickness, in order to maximise 10C to
11C ratio while maintaining high 10C production yields.
For commercially available isotopic enrichments, in
saturation condition for both isotopes, the level of the
11C impurity is 12% for 11MeV proton beam produc-
tion. This level decreases for higher beam energy values
as a result from a more favourable ratio between thecross sections. The optimum determined energy range
(Alves et al., 2000) corresponds to a beam degradation
from 28 to 14MeV, corresponding to an isotopic
impurity level of 3.2%.
In terms of thick target yield, in a 11MeV cyclotron
about 450MBq of 10C can be produced, per mA in
saturation, using the 10B(p,n)10C reaction. The same
reaction yields more than 1800MBqper mA, in satura-
tion, using an 18MeV cyclotron.
For practical production (Jensen et al., 1998; Nickles
et al., 1998), molten 10B2
18O3 on a rhenium mesh support
can be used. The target material enrichment should be
highest possible to reduce 11C and 13N production. The
primary product is 10CO, which is swept from the target
in a tuned helium flow to a furnace system based on
CuO, yielding pure 10CO2, which can be administered
through a normal T-piece breathing mask (Fig. 1).
The system of Fig. 1 was implemented within a
hospital PET centre with cyclotron, the Cyclotron and
PET Center of Rigshospitalet, Denmark’s National
Hospital in Copenhagen. All research and development
work, proving that methodological and technical
innovation is possible in one of the most fundamental
components of the PET technique—radionuclide pro-
duction, was entirely performed in this clinically
oriented centre.References
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